What is emphysematous cystitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Emphysematous cystitis should be treated with early appropriate antibiotics targeting common pathogens like Escherichia coli and Klebsiella species, with a general treatment approach mirroring that for nonemphysematous UTIs, as recommended by the most recent guidelines 1. The treatment of emphysematous cystitis lacks robust data, with recommendations mostly relying on clinical judgment and case studies. However, the use of broad-spectrum antibiotics is reasonable, with a treatment duration of 7 to 14 days (adjusted per clinical response) being considered reasonable by most authors 1. Some key points to consider in the treatment of emphysematous cystitis include:

  • The use of antibiotics such as fluoroquinolones, third-generation cephalosporins, or carbapenems, with adjustments based on culture results
  • Immediate hospitalization for severe cases
  • Strict glycemic control if diabetic, with blood glucose maintained below 180 mg/dL
  • Adequate hydration and urinary catheterization for bladder decompression if needed
  • Surgical intervention for complications like bladder necrosis It is essential to note that emphysematous cystitis can progress to emphysematous pyelonephritis or urosepsis if left untreated, with mortality rates of 7-10%, making early diagnosis and aggressive management crucial 1. The gas formation in emphysematous cystitis results from fermentation of glucose or albumin by bacteria such as E. coli and Klebsiella, creating carbon dioxide and hydrogen within bladder tissues. Percutaneous catheter drainage, along with antibiotics, shows lower mortality for emphysematous pyelonephritis and is advisable in severe cases to include broader coverage until culture results are available 1.

From the Research

Definition and Characteristics of Emphysematous Cystitis

  • Emphysematous cystitis is a rare urologic condition characterized by the presence of gas within the bladder wall and lumen 2, 3, 4.
  • It is typically associated with abdominal pain, hematuria, and dysuria, and can lead to complications such as bladder rupture, necrosis, and septic shock 2, 3.

Predisposing Factors

  • Emphysematous cystitis has been associated with several predisposing medical conditions, including:
    • Diabetes mellitus 2, 3, 4, 5
    • Recurrent urinary tract infections 2, 3
    • Immunosuppression 2, 3, 4
  • However, it can also occur in patients without these traditional risk factors 2, 4.

Diagnosis and Treatment

  • Diagnosis is typically made through radiological studies, such as CT scans or radiography 2, 3, 4, 5.
  • Treatment requires prompt urinary drainage, antibiotic coverage, and correction of underlying causes 3, 4, 6, 5.
  • Conservative management with antibiotics and bladder catheterization is often successful, but surgical intervention may be necessary in severe cases 3, 6, 5.

Clinical Presentation and Outcomes

  • The presentation of emphysematous cystitis can range from asymptomatic to life-threatening cystitis 3, 4, 6.
  • Early detection and prompt treatment are crucial to mitigate the risk of adverse outcomes and improve patient outcomes 2, 3, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Emphysematous Cystitis: A Rare Urologic Emergency.

The American journal of case reports, 2023

Research

Emphysematous cystitis.

Urology, 2010

Research

[Emphysematous cystitis and emphysematous pyelonephritis].

Revista espanola de geriatria y gerontologia, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.